Literature DB >> 27571724

Risk stratification for healthcare planning in women with gestational diabetes mellitus.

S H Koning1, K A Scheuneman, H L Lutgers, F J Korteweg, G van den Berg, K M Sollie, A Roos, A J van Loon, T P Links, K M van Tol, K Hoogenberg, P P van den Berg, B H R Wolffenbuttel.   

Abstract

BACKGROUND: To identify relevant factors predicting the need for insulin therapy in women with gestational diabetes mellitus (GDM) and secondly to determine a potential 'low- risk' diet-treated group who are likely to have good pregnancy outcomes.
METHODS: A retrospective analysis between 2011-2014. Multivariable backward stepwise logistic regression was used to identify the predictors of the need for insulin therapy. To identify a 'low-risk' diet-treated group, the group was stratified according to pregnancy complications. Diet-treated women with indications for induction in secondary care were excluded.
RESULTS: A total of 820 GDM women were included, 360 (44%) women required additional insulin therapy. The factors predicting the need for insulin therapy were: previous GDM, family history of diabetes, a previous infant weighing ≥ 4500 gram, Middle-East/North-African descent, multiparity, pre-gestational BMI ≥ 30 kg/m2, and an increased fasting glucose level ≥ 5.5 mmol/l (OR 6.03;CI 3.56-10.22) and two-hour glucose level ≥ 9.4 mmol/l after a 75-gram oral glucose tolerance test at GDM diagnosis. In total 125 (54%) women treated with diet only had pregnancy complications. Primiparity and higher weight gain during pregnancy were the best predictors for complications (predictive probability 0.586 and 0.603).
CONCLUSION: In this GDM population we found various relevant factors predicting the need for insulin therapy. A fasting glucose level ≥ 5.5 mmol/l at GDM diagnosis was by far the strongest predictor. Women with GDM who had good glycaemic control on diet only with a higher parity and less weight gain had a lower risk for pregnancy complications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27571724

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  5 in total

1.  Estimating the Risk of Insulin Requirement in Women Complicated by Gestational Diabetes Mellitus: A Clinical Nomogram.

Authors:  Runyu Du; Ling Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-01       Impact factor: 3.168

2.  New diagnostic criteria for gestational diabetes mellitus and their impact on the number of diagnoses and pregnancy outcomes.

Authors:  Sarah H Koning; Jelmer J van Zanden; Klaas Hoogenberg; Helen L Lutgers; Alberdina W Klomp; Fleurisca J Korteweg; Aren J van Loon; Bruce H R Wolffenbuttel; Paul P van den Berg
Journal:  Diabetologia       Date:  2017-11-22       Impact factor: 10.122

3.  Associations between maternal characteristics and pharmaceutical treatment of gestational diabetes: an analysis of the UK Born in Bradford (BiB) cohort study.

Authors:  Gilberte Martine-Edith; William Johnson; Eugenie Hunsicker; Mark Hamer; Emily S Petherick
Journal:  BMJ Open       Date:  2021-11-03       Impact factor: 2.692

4.  Development and validation of prediction models for gestational diabetes treatment modality using supervised machine learning: a population-based cohort study.

Authors:  Lauren D Liao; Assiamira Ferrara; Mara B Greenberg; Amanda L Ngo; Juanran Feng; Zhenhua Zhang; Patrick T Bradshaw; Alan E Hubbard; Yeyi Zhu
Journal:  BMC Med       Date:  2022-09-15       Impact factor: 11.150

5.  Pregnancy outcomes in women with gestational diabetes mellitus diagnosed according to the WHO-2013 and WHO-1999 diagnostic criteria: a multicentre retrospective cohort study.

Authors:  Eva A R Goedegebure; Sarah H Koning; Klaas Hoogenberg; Fleurisca J Korteweg; Helen L Lutgers; Mattheus J M Diekman; Eva Stekkinger; Paul P van den Berg; Joost J Zwart
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-10       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.